The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Cavan John T since 2017.
This trader's CIK number is 1503738.
At the time of last reporting, Cavan John T was the Chief Financial Officer of Hepion Pharmaceuticals, Inc.. (stock ticker symbol HEPA).
Also see all insider trading activities at Hepion Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | HEPA | 10,000 | $20,000 | 0 | $0 | 0 | $0 |
| 2020 | HEPA | 4,500 | $7,290 | 0 | $0 | 0 | $0 |
| 2017 | HEPA | 20,000 | $13,000 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-02-18 | HEPA | Buy | 10,000 | 2.00 | 20,000 |
| 2020-11-25 | HEPA | Buy | 4,500 | 1.62 | 7,290 |
| 2017-06-20 | CTRV | Buy | 20,000 | .65 | 13,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Cavan John T (Chief Financial Officer of Hepion Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.